LSLorenzo Spagnuolo

Lorenzo Spagnuolo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lorenzo Spagnuolo has a total of 10 co-authors. Here are the top co-authors by number of shared publications:

  • Anne Oberson

    Chair of Pharmacology Department of Medicine Faculty of Science University of Fribourg Fribourg Switzerland

    1 shared publication
  • Carole Bourquin

    School of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland

    1 shared publication
  • Christian Hotz

    Chair of Pharmacology Department of Medicine Faculty of Science University of Fribourg Fribourg Switzerland

    1 shared publication
  • Inès Mottas

    Chair of Pharmacology Department of Medicine Faculty of Science University of Fribourg Fribourg Switzerland

    1 shared publication
  • Jerome Widmer

    Chair of Pharmacology Department of Medicine Faculty of Science University of Fribourg Fribourg Switzerland

    1 shared publication
  • Marco E. Bianchi

    Division of Genetics and Cell Biology San Raffaele University and Scientific Institute Milan Italy

    1 shared publication

Latest Publications

  • Open Access

    HMGB1 promotes CXCL12‐dependent egress of murine B cells from Peyer's patches in homeostasis

    by Lorenzo Spagnuolo, Viola Puddinu, Noémie Boss, Thibaud Spinetti, Anne Oberson, Jerome Widmer, Inès Mottas, Christian Hotz, Marco E. Bianchi, Mariagrazia Uguccioni, et al.

    High mobility group box-1 protein (HMGB1) is an alarmin that, once released, promotes inflammatory responses, alone and as a complex with the chemokine CXCL12. Here we report that the HMGB1-CXCL12 complex plays an essential role also in homeostasis by controlling the migration of B lymphocytes. We show that extracellular HMGB1 is critical for the CXCL12-dependent egress of B cells from the Peyer's patches (PP). This promigratory function of the complex was restricted to the PPs, since HMGB1 was not required for B-cell migratory processes in other locations. Accordingly, we detected higher constitutive levels of the HMGB1-CXCL12 complex in PPs than in other lymphoid organs. HMGB1-CXCL12 in vivo inhibition was associated with a reduced basal IgA production in the gut. Collectively, our results demonstrate a role for the HMGB1-CXCL12 complex in orchestrating B-cell trafficking in homeostasis, and provide a novel target to control lymphocyte migration in mucosal immunity. This article is protected by copyright. All rights reserved